This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2024 Aug;20(8):501.

doi: 10.1038/s41574-024-00997-7.

Author Correction: Targeting the incretin system in obesity and type 2 diabetes mellitus

Saleem Ansari¹, Bernard Khoo², Tricia Tan³

Affiliations

Affiliations

¹ Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK.
² Department of Endocrinology, Division of Medicine, Royal Free Campus, University College London, London, UK.
³ Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK. t.tan@imperial.ac.uk.

PMID: 38714910
DOI: 10.1038/s41574-024-00997-7

Published Erratum

Author Correction: Targeting the incretin system in obesity and type 2 diabetes mellitus

Saleem Ansari et al. Nat Rev Endocrinol. 2024 Aug.

. 2024 Aug;20(8):501.

doi: 10.1038/s41574-024-00997-7.

Authors

Saleem Ansari¹, Bernard Khoo², Tricia Tan³

Affiliations

¹ Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK.
² Department of Endocrinology, Division of Medicine, Royal Free Campus, University College London, London, UK.
³ Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK. t.tan@imperial.ac.uk.

PMID: 38714910
DOI: 10.1038/s41574-024-00997-7

No abstract available

PubMed Disclaimer

Erratum for

Targeting the incretin system in obesity and type 2 diabetes mellitus.
Ansari S, Khoo B, Tan T. Ansari S, et al. Nat Rev Endocrinol. 2024 Aug;20(8):447-459. doi: 10.1038/s41574-024-00979-9. Epub 2024 Apr 17. Nat Rev Endocrinol. 2024. PMID: 38632474 Review.

Similar articles

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
Vilsbøll T, Krarup T, Sonne J, Madsbad S, Vølund A, Juul AG, Holst JJ. Vilsbøll T, et al. J Clin Endocrinol Metab. 2003 Jun;88(6):2706-13. doi: 10.1210/jc.2002-021873. J Clin Endocrinol Metab. 2003. PMID: 12788877
Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes.
Tan Q, Akindehin SE, Orsso CE, Waldner RC, DiMarchi RD, Müller TD, Haqq AM. Tan Q, et al. Front Endocrinol (Lausanne). 2022 Mar 1;13:838410. doi: 10.3389/fendo.2022.838410. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35299971 Free PMC article. Review.
Novel incretin-based agents and practical regimens to meet needs and treatment goals of patients with type 2 diabetes mellitus.
Garber AJ. Garber AJ. J Am Osteopath Assoc. 2011 Jul;111(7 Suppl 5):S20-30. J Am Osteopath Assoc. 2011. PMID: 21813733 Review.
Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus.
Nisal K, Kela R, Khunti K, Davies MJ. Nisal K, et al. BMC Med. 2012 Nov 30;10:152. doi: 10.1186/1741-7015-10-152. BMC Med. 2012. PMID: 23198896 Free PMC article. Review.
Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity.
Opinto G, Natalicchio A, Marchetti P. Opinto G, et al. Arch Physiol Biochem. 2013 Oct;119(4):170-8. doi: 10.3109/13813455.2013.812664. Epub 2013 Jul 16. Arch Physiol Biochem. 2013. PMID: 23859800 Review.

See all similar articles

Cited by

Metabolic alliance: pharmacotherapy and exercise management of obesity.
Butragueño J, Ruiz JR. Butragueño J, et al. Nat Rev Endocrinol. 2024 Sep;20(9):505-506. doi: 10.1038/s41574-024-01006-7. Nat Rev Endocrinol. 2024. PMID: 38839938 No abstract available.
Overweight and obesity significantly increase colorectal cancer risk: a meta-analysis of 66 studies revealing a 25-57% elevation in risk.
Ungvari Z, Fekete M, Varga P, Lehoczki A, Fekete JT, Ungvari A, Győrffy B. Ungvari Z, et al. Geroscience. 2025 Jun;47(3):3343-3364. doi: 10.1007/s11357-024-01375-x. Epub 2024 Oct 8. Geroscience. 2025. PMID: 39379738 Free PMC article.
Unraveling the complexities of diet induced obesity and glucolipid dysfunction in metabolic syndrome.
Dutta B, Tripathy A, Archana PR, Kamath SU. Dutta B, et al. Diabetol Metab Syndr. 2025 Jul 22;17(1):292. doi: 10.1186/s13098-025-01837-y. Diabetol Metab Syndr. 2025. PMID: 40696355 Free PMC article. Review.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group